Literature DB >> 11916002

The revised NASPE/BPEG generic code for antibradycardia, adaptive-rate, and multisite pacing. North American Society of Pacing and Electrophysiology/British Pacing and Electrophysiology Group.

Alan D Bernstein1, Jean-Claude Daubert, Ross D Fletcher, David L Hayes, Berndt Lüderitz, Dwight W Reynolds, Mark H Schoenfeld, Richard Sutton.   

Abstract

In light of evolving pacemaker technology and increasing interest in multisite pacing, the Committee on the Development of Position Statements (CDPS) of the North American Society of Pacing and Electrophysiology (NASPE) created an ad hoc Pacemaker Mode Code Task Force in April 2001 under the chairmanship of David L. Hayes, MD, for the purpose of bringing the NASPE/British Pacing and Electrophysiology Group (BPEG) Generic Pacemaker Code (NBG Code) up to date. The task force, whose members are the authors of this article, designed a revised NBG Code in which three major issues were taken into account. First, it was recognized that all modern pacemakerpulse generators are capable of extensive bidirectional communication with an external programming device, making them "communicating" pulse generators as defined by the current (1987) NBG Code. Second, it was decided that a means of providing basic information regarding the location of multisite pacing would be a useful ingredient of the NBG Code. Third, in view of the extensive antibradycardia pacing capabilities common in modern implantable cardioverter defibrillators and the availability of the NASPE/BPEG Defibrillator Code (NBD Code), it was considered unnecessary for the NBG Code to address the presence or absence of antitachycardia features. The resulting updated version of the NBG Code as described herein was endorsed by the BPEG on September 20, 2001 and adopted by the NASPE Board of Trustees on October 18, 2001. The structure of the revised NBG Code differs from that of the previous version in two respects alone: Position IV specifies only the presence or absence of rate modulation, and Position V specifies only the location or absence of multisite pacing (i.e., biatrial or biventricular pacing with at least two stimulation sites in each case) more than one stimulation site in any single cardiac chamber, or any combination of these. The revised NBG Code is deliberately configured to avoid confusion with earlier mode codes, and it is the authors' hope that it will serve as an enhanced resource for communication among those engaged in every phase of the multidisciplinary practice of cardiac rhythm management.

Mesh:

Year:  2002        PMID: 11916002     DOI: 10.1046/j.1460-9592.2002.00260.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  25 in total

1.  Experimental study on malfunction of pacemakers due to exposure to different external magnetic fields.

Authors:  Maria Tiikkaja; Tommi Alanko; Harri Lindholm; Maila Hietanen; Juha Hartikainen; Lauri Toivonen
Journal:  J Interv Card Electrophysiol       Date:  2012-01-11       Impact factor: 1.900

Review 2.  A practical approach to perioperative management of cardiac implantable electronic devices.

Authors:  Pow-Li Chia; David Foo
Journal:  Singapore Med J       Date:  2015-10       Impact factor: 1.858

3.  An eight-year prospective controlled study about the safety and diagnostic value of cardiac and non-cardiac 1.5-T MRI in patients with a conventional pacemaker or a conventional implantable cardioverter defibrillator.

Authors:  Pierpaolo Lupo; Riccardo Cappato; Giovanni Di Leo; Francesco Secchi; Giacomo D E Papini; Sara Foresti; Hussam Ali; Guido M G De Ambroggi; Antonio Sorgente; Gianluca Epicoco; Paola M Cannaò; Francesco Sardanelli
Journal:  Eur Radiol       Date:  2018-01-09       Impact factor: 5.315

Review 4.  Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy.

Authors:  Mohammed Qintar; Abdulrahman Morad; Hazem Alhawasli; Khaled Shorbaji; Belal Firwana; Adib Essali; Waleed Kadro
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

5.  [Guidelines for heart pacemaker therapy].

Authors:  B Lemke; B Nowak; D Pfeiffer
Journal:  Z Kardiol       Date:  2005-10

Review 6.  [Who dictates the rhythm which must be followed? : Pacemakers and implantable cardioverter defibrillators in anesthesiology].

Authors:  M Bischoff; A Walther; C Serf
Journal:  Anaesthesist       Date:  2011-08       Impact factor: 1.041

7.  Management of postoperative junctional ectopic tachycardia in pediatric patients: a survey of 30 centers in Germany, Austria, and Switzerland.

Authors:  Andreas Entenmann; Miriam Michel; Ulrike Herberg; Nikolaus Haas; Matthias Kumpf; Matthias Gass; Friedemann Egender; Roman Gebauer
Journal:  Eur J Pediatr       Date:  2017-07-21       Impact factor: 3.183

8.  [Advanced classification for cardiovascular devices].

Authors:  Andreas Schuchert
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2016-12

9.  Design and Testing of a Transcutaneous RF Recharging System for a Fetal Micropacemaker.

Authors:  Adriana N Vest; Li Zhou; Xuechen Huang; Viktoria Norekyan; Yaniv Bar-Cohen; Ramen H Chmait; Gerald Eli Loeb
Journal:  IEEE Trans Biomed Circuits Syst       Date:  2017-02-13       Impact factor: 3.833

10.  Post operative temporary epicardial pacing: When, how and why?

Authors:  Anjan S Batra; Seshadri Balaji
Journal:  Ann Pediatr Cardiol       Date:  2008-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.